{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:44:36Z","timestamp":1791931476518,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016350","name":"Massey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ajog.2020.08.004","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T19:16:50Z","timestamp":1596914210000},"page":"739.e1-739.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia"],"prefix":"10.1016","volume":"223","author":[{"given":"Michael J.","family":"Paidas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan T.N.","family":"Tita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Macones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Ehrenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth W.","family":"Triche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Streisand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everett F.","family":"Magann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell P.","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika F.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounira A.","family":"Habli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A.","family":"Grotegut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri A.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Amon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y.","family":"How","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Grobman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie E.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Scifres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha M.","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.08.004_bib1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ajog.2004.03.050","article-title":"Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks\u2019 gestation","volume":"190","author":"Haddad","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.004_bib2","doi-asserted-by":"crossref","first-page":"247.e1","DOI":"10.1016\/j.ajog.2008.06.086","article-title":"Expectant management of severe preeclampsia at less than 27 weeks\u2019 gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management","volume":"199","author":"Bombrys","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.004_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0029-1214243","article-title":"Expectant management of severe preeclampsia at 27(0\/7) to 33(6\/7) weeks\u2019 gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management","volume":"26","author":"Bombrys","year":"2009","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2020.08.004_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.004_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajog.2011.07.017","article-title":"Evaluation and management of severe preeclampsia before 34 weeks\u2019 gestation","volume":"205","author":"Sibai","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.004_bib6","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.004_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.08.004_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.08.004_bib9","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJMcibr1817501","article-title":"Preventing preeclampsia by silencing soluble Flt-1?","volume":"380","author":"Robertson","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.08.004_bib10","first-page":"10","article-title":"Role of antithrombin III as a regulator of in\u00a0vivo coagulation","volume":"28","author":"Bauer","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ajog.2020.08.004_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1160\/TH03-07-0460","article-title":"Antithrombin reduces ischemia\/reperfusion-induced liver injury in rats by activation of cyclooxygenase-1","volume":"92","author":"Harada","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2020.08.004_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2007.02869.x","article-title":"Antithrombin inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by monocytes in\u00a0vitro through inhibition of Egr-1 expression","volume":"6","author":"Komura","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2020.08.004_bib13","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.thromres.2014.02.014","article-title":"Clinical syndromes associated with acquired antithrombin deficiency via microvascular leakage and the related risk of thrombosis","volume":"133","author":"Ornaghi","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2020.08.004_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/17512433.2014.944501","article-title":"Upcoming drugs for the treatment of preeclampsia in pregnant women","volume":"7","author":"Ornaghi","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.ajog.2020.08.004_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1248\/bpb.19.819","article-title":"Antithrombin III prevents blood pressure elevation and proteinuria induced by high salt intake in pregnant stroke-prone spontaneously hypertensive rats","volume":"19","author":"Shinyama","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ajog.2020.08.004_bib16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00005344-199605000-00013","article-title":"Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia","volume":"27","author":"Shinyama","year":"1996","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.ajog.2020.08.004_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-2004-815632","article-title":"Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study","volume":"29","author":"Kobayashi","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ajog.2020.08.004_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/s-0037-1614071","article-title":"Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group","volume":"84","author":"Maki","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2020.08.004_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0049-3848(90)90210-4","article-title":"Elimination of antithrombin III concentrate in healthy pregnant and preeclamptic women with an acquired antithrombin III deficiency","volume":"58","author":"Weiner","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2020.08.004_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(00)00268-X","article-title":"Treatment with antithrombin III (AT III) concentrate in pre-eclampsia","volume":"71","author":"Paternoster","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.08.004_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1160\/TH03-06-0388","article-title":"Efficacy of AT in pre-eclampsia: a case-control prospective trial","volume":"91","author":"Paternoster","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2020.08.004_bib22","first-page":"301","article-title":"Antithrombin III activity in women with hypertension during pregnancy","volume":"65","author":"Weiner","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.004_bib23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993\u20132012","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.08.004_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2016.01.024","article-title":"High dose antithrombin supplementation in early preeclampsia: a randomized, double blind, placebo-controlled study","volume":"140","author":"D\u2019Angelo","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2020.08.004_bib25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0002-9378(84)90634-3","article-title":"Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity","volume":"148","author":"Weenink","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.004_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and meta-analysis to revise the Fenton growth chart\u00a0for preterm infants","volume":"13","author":"Fenton","year":"2013","journal-title":"BMC Pediatr"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820308322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820308322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:57:32Z","timestamp":1774461452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820308322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0002937820308322"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.08.004","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}